Genscript Biotech Corporation (HKG:1548)
Hong Kong
· Delayed Price · Currency is HKD 13.62
+0.09 (0.67%)
Apr 29, 2026, 4:08 PM HKT
Genscript Biotech Market Cap
Genscript Biotech has a market cap or net worth of 29.80 billion as of April 29, 2026. Its market cap has increased by 13.09% in one year.
Market Cap
29.80B
Enterprise Value
26.20B
Revenue
7.47B
Ranking
n/a
PE Ratio
n/a
Stock Price
13.62
Market Cap Chart
Since December 30, 2015, Genscript Biotech's market cap has increased from 2.11B to 29.80B, an increase of 1,311.06%. That is a compound annual growth rate of 29.18%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| InnoCare Pharma | 28.42B |
| Shanghai Bao Pharmaceuticals | 26.78B |
| Duality Biotherapeutics | 25.45B |
| TransThera Sciences (Nanjing) | 22.75B |
| Keymed Biosciences | 22.17B |
| Shanghai Henlius Biotech | 42.15B |
| Biocytogen Pharmaceuticals (Beijing) | 42.78B |
| Shanghai Junshi Biosciences | 43.50B |